mdl 100173 has been researched along with mdl 100240 in 4 studies
| Studies (mdl 100173) | Trials (mdl 100173) | Recent Studies (post-2010) (mdl 100173) | Studies (mdl 100240) | Trials (mdl 100240) | Recent Studies (post-2010) (mdl 100240) |
|---|---|---|---|---|---|
| 7 | 2 | 0 | 21 | 9 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, JI; Chang, J; Heath, TG; Kuo, BS; Massad, DD; Mathews, BS; Scott, DO; Toren, PC | 1 |
| Anderson, B; Beach, DC; Dage, RC; Flynn, GA; French, JF; Giroux, EL; Koehl, JR; Mehdi, S | 1 |
| Argenti, R; Emmons, GT; Jensen, BK; Martin, LL; Martin, NE | 1 |
| Barrett, JS; Brennan, B; Cirillo, I; Martin, NE | 1 |
2 trial(s) available for mdl 100173 and mdl 100240
| Article | Year |
|---|---|
Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Benzazepines; Female; Half-Life; Humans; Male; Neprilysin; Prodrugs; Pyridines | 2004 |
The effect of food on the pharmacokinetics of a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Benzazepines; Cross-Over Studies; Dietary Fats; Drug Administration Schedule; Eating; Fasting; Female; Food; Guidelines as Topic; Humans; Male; Prodrugs; Protease Inhibitors; Pyridines | 2004 |
2 other study(ies) available for mdl 100173 and mdl 100240
| Article | Year |
|---|---|
Quantification of a dual angiotensin I-converting enzyme-neutral endopeptidase inhibitor and the active thiol metabolite in dog plasma by high-performance liquid chromatography with ultraviolet absorbance detection.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Chromatography, High Pressure Liquid; Dogs; Drug Stability; Freezing; Neprilysin; Osmolar Concentration; Peptidyl-Dipeptidase A; Protease Inhibitors; Pyridines; Reproducibility of Results; Spectrophotometry, Ultraviolet; Sulfhydryl Compounds | 1995 |
Characterization of a dual inhibitor of angiotensin I-converting enzyme and neutral endopeptidase.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Benzazepines; Bradykinin; Male; Molecular Structure; Neprilysin; Peptidyl-Dipeptidase A; Prodrugs; Pyridines; Rats; Rats, Sprague-Dawley | 1994 |